Pancreatic Cancer Research

ResearcherTokyo Medical UniversityActive in the last 2 years

Naokazu Chiba

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1846-5987; OpenAlex author ID A5046656997, A5123887054. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. SOX8 mediates the crosstalk between KRAS and TGF-β pathways to promote the malignant progression of pancreatic cancer. Co-author DOI 10.62347/znlo9432↗
  2. HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer. Co-author DOI 10.18632/oncotarget.28235↗
  3. Prognostic Significance of Plasma Fibrinogen/Serum Albumin Ratio in the Postoperative Outcome of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.14727↗
  4. Overexpression of hydroxyproline via EGLN/HIF1A is associated with distant metastasis in pancreatic cancer. Co-author PMID 32905516↗
  5. [The Efficacy of Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer]. Co-author PMID 26805072↗
  6. Computer assisted surgery, preoperative planning and navigation for pancreatic cancer. Co-author DOI 10.1002/jhbp.84↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeyuki Kawachi · 5 shared papers, 2014–2022 · strength 0.48
  2. Toru Sano · 4 shared papers, 2015–2022 · strength 0.44
  3. Koichi Tomita · 4 shared papers, 2015–2022 · strength 0.44
  4. Makoto Sunamura · 1 shared paper, 2020 · strength 0.10
  5. Minoru Kitago · 1 shared paper, 2014 · strength 0.04
  6. Yuta Abe · 1 shared paper, 2014 · strength 0.04
  7. Yuko Kitagawa · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.